Clinical trial
Predictive Markers of Glitazone Efficacy in Diabetic Patients - Pilot Study
NCT00481429 · Imperial College London, Other · Withdrawn
Key facts
| NCT number | NCT00481429 |
|---|---|
| Title | Predictive Markers of Glitazone Efficacy in Diabetic Patients - Pilot Study |
| Official title | Evaluation of Predictive Markers of Glitazone Efficacy in Diabetic Patients - Pilot Study |
| Lead sponsor | Imperial College London, Other |
| Collaborators | GlaxoSmithKline Industry |
| Status | Withdrawn |
| Study type | Observational |
| Conditions | Diabetes Mellitus, Type 2 |
| Intervention type | Drug |
| Interventions | Rosiglitazone |
| Enrollment | 0 |
| Start date | May 1, 2007 |
| Primary completion | Jan 1, 2008 |
| Completion | Jan 1, 2008 |
| First posted | Jun 1, 2007 |
| Last update posted | Jul 10, 2019 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: